Here, the authors show in two independent cohorts that the calcium‐sensing receptor (CaSR) is down‐regulated in gastroenteropancreatic neuroendocrine tumours and that this reduced expression is likely due to alterations in DNA methylation and chromatin organisation. Here, CASR is linked to neuroendocrine neoplasm.